This program funds investigator-initiated randomized clinical trials addressing under-researched medical and social needs. It excludes non-randomized and uncontrolled trials. Applicants must submit a letter of intent and proposal via the mySNF platform, including support from clinical trial units and patient involvement. Up to CHF 5,000 is available for patient and public involvement costs in application preparation.
Eligible applicants are researchers who submit a letter of intent by May 26, 2026, and proposals by November 3, 2026. Support letters from clinical trial units and patient involvement are required.
